Human CCR2 Full Length Protein (VLP)

Customer Reviews
Cat. No. / Size
Price
Qty
CC2-H52P3-20ug
$620.00
CC2-H52P3-100ug
$1235.00
CC2-H52P3-500ug (250ug X 2)
$4305.00
ETA of in-stock products:2 business days

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    C-C chemokine receptor type 2, C-C CKR-2, CC-CKR-2, CC-CKR-2CKR2B, CCR2, CCR-2, CCR2A, CCR2B, CD192 antigen, CD192, chemokine (C-C motif) receptor 2, CKR2, CKR2A, CMKBR2, CMKBR2MGC111760, FLJ78302, MCP-1 receptor, MCP-1-R, MCP-1-RMGC103828, MGC168006, Monocyte chemoattractant protein 1 receptor, monocyte chemotactic protein 1 receptor

  • Source

    Human CCR2 Full Length Protein (VLP) (CC2-H52P3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Leu 360 (Accession # P41597-2).

    Predicted N-terminus: Met 1

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, pH7.4 with glycerol as protectant.

    Contact us for customized product form or formulation.

  • Shipping

    This product is supplied and shipped with dry ice, please inquire the shipping cost.

  • Storage

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 12 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     CCR2 ELISA

    Immobilized Human CCR2 Full Length Protein (VLP) (Cat. No. CC2-H52P3) at 5 μg/mL (100 μL/well) can bind Anti-CCR2 antibody with a linear range of 0.5-8 ng/mL (QC tested).

    Protocol
  • Identity-DLS

     CCR2 DLS

    The mean peak Radius of VLP is 80-120 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Customer Reviews
Writing Reviews

Background

The primary receptor for CCL2 (MCP-1), a major chemokine driving monocyte egress from bone marrow and recruitment to inflamed tissues. The CCR2-CCL2 axis promotes tumor-associated macrophage (TAM) accumulation and fibrosis. Antagonists aim to reprogram the immunosuppressive tumor stroma and treat inflammatory diseases.

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland